about
Calcitonin/calcitonin-related polypeptide, alphaAcrosin prepropeptideV-raf-leukemia viral oncogene 1Follicle stimulating hormone receptorThyroid stimulating hormone receptorAdenylate cyclase activating polypeptide 1Adrenergic receptor, beta 2Growth hormone releasing hormone receptorCyclase associated actin cytoskeleton regulatory protein 2G protein subunit alpha LGuanine nucleotide-binding protein G(s) subunit alpha isoforms shortRelaxin family peptide receptor 1Dopamine receptor D1Adenylate cyclase 6Adenylate cyclase 3Adenylate cyclase 9Adenylate cyclase 5Adenylate cyclase 8Adenylate cyclase 7Adenylate cyclase 2Adenylate cyclase 1Adenylate cyclase 4Calcitonin gene-related peptide 1 (prepro)Cyclase associated actin cytoskeleton regulatory protein 1Adenosine A3 receptorAdenosine A2b receptorLeucine rich repeat containing G protein-coupled receptor 5Leucine rich repeat containing G protein-coupled receptor 4Luteinizing hormone/choriogonadotropin receptorPurinergic receptor P2Y11Transmembrane and immunoglobulin domain containing 3Relaxin family peptide receptor 2Dopamine receptor D5Endothelin receptor type AVasoactive intestinal peptide receptor 2Calcitonin gene-related peptide 1Calmodulin 3Adenylate cyclase 1Adenylate cyclase 7Adenylate cyclase type 2
P682
A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptorExtraction of the adenylate cyclase-activating factor of bovine sperm and its identification as a trypsin-like proteaseRaf kinase activation of adenylyl cyclases: isoform-selective regulationPositive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cellsMolecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinomaPalmitoylation of the V2 vasopressin receptorComparison of human CAP and CAP2, homologs of the yeast adenylyl cyclase-associated proteinsStructure of the human pituitary adenylate cyclase activating polypeptide (PACAP) geneInduction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor
P921
Q14860528-5A74CEA2-9C07-4035-B577-22CA6B777F0CQ14864907-E8DD1619-4CE1-4F16-ABA8-72ECEBA1FFF8Q14903577-5D414144-1F04-4E54-826C-50A9D07393CDQ14904776-1D47C8A5-8DAD-4144-8C45-88DC1A3F4C42Q14904943-11942A40-1F89-4049-9122-FFBCAB667D42Q14907481-010A4807-ABAE-4357-917C-31E6860DBCB5Q14916386-44623BAA-3A29-437A-9C14-37A7F1EADF87Q15318754-C5F0D2C7-57E2-4515-B89A-9E99C4393E0AQ21096409-E3F4F832-5039-49DE-B171-0B5563F8AF10Q21106182-A4C781D2-D81D-4E07-8E5A-918B3CE810A8Q21106183-88B30156-9203-4D27-97ED-277444D330F6Q21108186-1B3C8460-DC08-49D3-97D0-62FD6B48342BQ21110867-9760BC3B-6281-473B-A960-FEE31917DB90Q21111191-094B49A5-529D-45BE-9CD3-B29FBF717746Q21111192-4557129E-DBA1-41B8-9EAC-67B9B67769FEQ21111193-6DC0E6D1-A072-4492-BC02-2253D92EC522Q21111195-5BC1CEBB-8427-4312-A7F0-6E4E534C4E68Q21111198-81DC6C49-4E2A-46FD-AFBF-8692B7CC595BQ21111200-5AF2A9C2-D039-46AB-87FF-CA1A96247F2FQ21111201-AA6B9F2E-53B9-4F41-84A0-C5D218DFA0B5Q21111202-524294B3-40FE-44F3-B391-86AFB9505391Q21111211-4CA488E7-D715-4735-97A3-D44A260C684BQ21111856-528ABA30-04C4-4CFA-BC86-EC1698E90CF0Q21112915-321FDA9C-97C5-440C-AA24-F9E7C10A3E0AQ21116154-B490EAC8-A266-4188-AEC1-44A8C68517F8Q21116164-6EC229E7-CDE3-4322-845E-B73209E3F826Q21121563-EAD77C8A-103C-4106-A19E-9EC7F798946DQ21121566-3AE53FDC-E281-41A5-AA0E-E584B31FB373Q21121615-AF4474A3-BE10-472A-9299-82589E854B56Q21121815-DC891BC5-F9FE-49D2-AD69-236DEB6094A5Q21125353-6CE137C3-10CA-4DAC-95A7-B385F04D46EEQ21127131-64E90CE9-0D3D-4FBC-BB38-707F48237267Q21131500-E623075D-DDE4-4603-9CDC-DBBE24ECC754Q21132004-934325D1-60F9-46CF-851D-A5904C0556C5Q21135904-D2126AED-7B8D-45E3-82CC-9067EAB1BD6CQ21494924-32D34055-0AA6-4861-BD4E-1A90FD40E0A9Q21494929-EDF6565A-04EE-4682-9FAF-60BFF2DE4501Q21495333-0184FCBA-0472-4DF4-85BB-5FB08D2331C5Q21495334-B8B658B3-C72D-4D11-B602-FC129B9921C6Q21495356-B0422DBF-4D7A-49B3-884A-F2CD1CF18102
P682
Q22009445-28B21EC3-E6E7-4F31-B296-A444A98A4FF3Q24300069-BE706641-B8CD-4B51-AE0C-3D119CC8D1E5Q24305062-E3279A7B-56E8-4147-B67F-1D17399966A9Q24313163-4C880A53-9F26-4AAC-83D0-11AEB4906138Q24314426-16709B8A-1BD2-439B-AA92-D71562573E49Q24318042-7C149B78-9FCE-467E-AA5B-3083807BE2DDQ24337306-B99EF35C-0ACF-4F39-A6D1-98B28A84F5D3Q28117551-3817605B-EFB7-4D63-8C8E-2426841A05C5Q28771768-8444B50E-9544-4C24-BAED-820B7C543F55
P921
description
Any process that initiates the activity of the inactive enzyme adenylate cyclase.
@en
biologisch proces
@nl
name
activation o adenylate cyclase activity
@sco
activation of adenylate cyclase activity
@en
type
label
activation o adenylate cyclase activity
@sco
activation of adenylate cyclase activity
@en
altLabel
GO:0007190
@en
adenylate cyclase activation
@en
adenylyl cyclase activation
@en
prefLabel
activation o adenylate cyclase activity
@sco
activation of adenylate cyclase activity
@en
P2888
P686
GO:0007190